FDA-SEC-and-PPS-ALL-seem-to-be-on-different-trajectories relative to projections in post.
Historically none of these relevant entities and technical measures are aligned with projections cited in the post.
Drug companies seem to have little interest in BIEL specifically. Potentially have an interest in the TAM but not the company BioElectronics. TAM --> Total Addressable Market en.wikipedia.org/wiki/Total_addressable_market